4//SEC Filing
Lu Hongbo 4
Accession 0001562180-22-006125
CIK 0001831363other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 8:30 PM ET
Size
12.5 KB
Accession
0001562180-22-006125
Insider Transaction Report
Form 4
Lu Hongbo
Director
Transactions
- Purchase
Common Stock
2022-08-12$2.98/sh+1,123,021$3,346,603→ 1,480,374 total(indirect: See Footnote) - Purchase
Pre-funded Warrants (right to buy)
2022-08-16$2.42/sh+1,500,000$3,629,850→ 1,500,000 total(indirect: See Footnote)Exercise: $0.00→ Common Stock (1,500,000 underlying) - Purchase
Common Stock
2022-08-15$2.99/sh+1,218$3,642→ 1,481,592 total(indirect: See Footnote) - Purchase
Common Stock
2022-08-16$2.42/sh+1,500,000$3,630,000→ 2,981,592 total(indirect: See Footnote)
Footnotes (5)
- [F1]The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $2.83 to $3.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The securities are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As a managing member of Vivo Opportunity, LLC, Hongbo Lu shares voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P. with four other managing members but disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein.
- [F3]The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $2.96 to $3.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]Vivo Opportunity Fund Holdings, L.P. acquired 1,500,000 shares of Common Stock at $2.42 per share and 1,500,000 pre-funded warrants at $2.4199 per warrant in an underwritten offering.
- [F5]The pre-funded warrants have no expiration date and are exercisable immediately, subject to a 4.99% beneficial ownership limit.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001767584
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 8:30 PM ET
- Size
- 12.5 KB